Literature DB >> 25242933

Prevalence of Pseudomonas aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with chronic periodontal infection.

Renata Souto1, Carina M Silva-Boghossian2, Ana Paula Vieira Colombo1.   

Abstract

P. aeruginosa and Acinetobacter spp. are important pathogens associated with late nosocomial pneumonia in hospitalized and institutionalized individuals. The oral cavity may be a major source of these respiratory pathogens, particularly in the presence of poor oral hygiene and periodontal infection. This study investigated the prevalence of P. aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with periodontal disease or health. Samples were obtained from 55 periodontally healthy (PH) and 169 chronic periodontitis (CP) patients. DNA was obtained from the samples and detection of P. aeruginosa and Acinetobacter spp. was carried out by multiplex and nested PCR. P. aeruginosa and Acinetobacter spp. were detected in 40% and 45% of all samples, respectively. No significant differences in the distribution of these microorganisms between men and women, subgingival biofilm and saliva samples, patients ≤ 35 and > 35 years of age, and smokers and non-smokers were observed regardless periodontal status (p > 0.05). In contrast, the frequencies of P. aeruginosa and Acinetobacter spp. in saliva and biofilm samples were significantly greater in CP than PH patients (p < 0.01). Smokers presenting P. aeruginosa and high frequencies of supragingival plaque were more likely to present CP than PH. P. aeruginosa and Acinetobacter spp. are frequently detected in the oral microbiota of CP. Poor oral hygiene, smoking and the presence of P. aeruginosa are strongly associated with periodontitis.

Entities:  

Keywords:  Acinetobacter spp.; PCR; Pseudomonas aeruginosa; periodontitis; saliva; subgingival biofilm

Mesh:

Substances:

Year:  2014        PMID: 25242933      PMCID: PMC4166274          DOI: 10.1590/s1517-83822014000200017

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


Introduction

Periodontal diseases are bacterial infections associated with a complex microbiota of the dental biofilm that induces a local and systemic inflammatory response, leading to periodontal tissue destruction (Page and Kornam, 1997; Paster ; Socransky ). The microbial diversity of the human oral cavity has been recognized for decades, and over 700 species have been identified in this habitat (Paster ). In addition to the resident oral species, studies have shown that the oral cavity harbours high proportions of various medically important pathogens, particularly in individuals with poor oral hygiene, periodontal diseases and/or immunosuppression (Ali , 1996; Botero ; Colombo , 2009; Da Silva-Boghossian ; Fritschi ; Gonçalves ; Persson ; Slots , 1990; Souto and Colombo 2008; Souto ). Conceivably, these species may disseminate to distant body sites increasing the risk for systemic infectious conditions such as bacterial pneumonia (Paju and Scannapieco, 2007; Scannapieco, 1998; Scannapieco ). Pseudomonas aeruginosa and Acinetobacter spp. are major respiratory pathogens associated with late-onset nosocomial pneumonia in hospitalized and institutionalized individuals (Chastre and Fagon, 2002). P. aeruginosa can be identified in a range of infections, especially those with a tendency to become chronic such as lung infections in cystic fibrosis patients (Wagner and Iglewski, 2008). This species presents many virulence properties including the ability to produce and secrete extracellular enzymes and toxins (Pihl ; Smith and Iglewski, 2003, Woods ) to adhere to and form biofilms on tissues and abiotic surfaces (Pihl ; Smith and Iglewski, 2003), as well as to present resistance to many antibiotics (Slots , 1990). Acinetobacter spp. are a major concern in nosocomial infections due to their rapid development of multi-drug resistance, surviving desiccation and persistence in the environment for long periods of time (Fourrier ; Karlowsky ; Luna ). These organisms are associated with bacteremia, pulmonary infections, meningitis, diarrhea and notorious nosocomial infections with mortality rates of 20 to 60% (Luna ). Transmission is via person-to-person contact, contaminated water, food and hospital equipment (Agodi ; Luna ). The prevalence of Pseudomonas and Acinetobacter spp. in subjects with periodontal diseases may vary widely among different populations (Ali , 1996; Colombo ; Persson ; Slots , 1990; Slots ; Souto ). These pathogens have also been associated with treatment failure in patients with refractory periodontitis (Colombo , 2009). The role of these microorganisms in the etiology and pathogenesis of periodontal diseases is unclear. Regardless, we hypothesized that the existence of disease may increase colonization of the oral microbiota by these species. The aim of this study was to determine the carriage rate of P. aeruginosa and Acinetobacter spp. in the subgingival biofilm and saliva of subjects with periodontal health or chronic periodontitis.

Methods

Subject population and clinical diagnosis

Two hundred and twenty four adult subjects who sought dental treatment at the Dental School of the Federal University of Rio de Janeiro, Brazil were recruited for the study. Informed consent was obtained from all enrolled individuals. The study protocol was approved by the Review Committee for Human Subjects of the Clementino Fraga Filho University Hospital. Exclusion criteria included pregnancy, use of local or systemic antimicrobial agents within 6 months prior to the entry into the study, diabetes and other systemic conditions that could affect the periodontal status. All subjects had at least 10 natural teeth and were over 18 years of age. During the first visit, subjects were submitted to an anamnesis questionnaire, and information regarding age, gender and smoking status was obtained. Smoking was recorded as never-having-smoked and smoker (current or former smokers). Periodontal clinical measurements were performed at six sites per tooth and included probing depth (PD), clinical attachment level (CAL), presence or absence of supragingival biofilm (SB), bleeding on probing (BOP) and suppuration (SUP). After initial clinical evaluation, subjects were categorized as periodontally healthy (PH, n = 55) or chronic periodontitis (CP, n = 169). The PH controls had no sites with PD and/or CAL > 3 mm and no more than 10% of sites with BOP. CP patients presented at least 10% of teeth with PD and/or CAL 3 5 mm, or at least 15% of teeth with PD and/or CAL 3 4 mm, and > 10% of sites with BOP. After clinical examination and sampling, subjects with evidence of destructive periodontal disease were treated for periodontitis by full mouth scaling and root planning under local anesthetic and instructions in proper home care procedures in the Department of Dental Clinic at the Federal University of Rio de Janeiro.

Sampling

After removal of supragingival biofilm with sterile gauze, subgingival biofilm samples were taken of up to 6 sites with PD ≥ 4 mm and BOP from CP patients, and from 3 randomly selected sites with PD < 4 mm and no BOP from PH individuals using sterile periodontal curettes (Hu-Friedy, Chicago, IL). For each patient, samples were pooled and placed in Eppendorf tubes containing 500 μL of TE (Tris-HCl 10 mM, EDTA 1 mM, pH 7.6). For saliva samples, patients were not allowed to clean their teeth or to eat 30 min before sampling. They rinsed out their mouths with 10 mL of 0.9% sterile saline for 60 s, and the mouthwashes were collected in sterile plastic recipients. All samples were stored in a freezer at −20 °C.

Isolation of bacterial DNA

Bacterial DNA was extracted from saliva and subgingival biofilm samples according to the methodology described by Laine . Briefly, samples were centrifuged at 300 × g for 10 min. The pellet was washed twice in 0.9% saline, re-suspended in 100 μL of 50 mM NaOH and boiled for 10 min. Samples were then neutralized with 14 μL of 1 M Tris (pH 7.5) and centrifuged at 14,000 × g for 3 min. Supernatants were collected and stored at −20 °C until PCR amplification was performed.

Detection of P. aeruginosa and Acinetobacter spp. by multiplex and nested PCR

For PCR detection of P. aeruginosa, two sets of primers were used: one set (PS1, 5′-ATGAACAACGTTCTGAAATTCTCTGCT-3′ and PS2, 5′-CTTGCGGCTGGCTTTTTCCAG-3′) consisted of primers corresponding to the beginning and the end of the open reading frame of the OprI gene (De Vos ), while the other set of primers (PAL1, 5′-ATGGAAATGCTGAAATTCGGC-3′ and PAL2, 5′-CTTCTTCAGCTCGACGCGGACG-3′) corresponded to the open reading frame of the OprL gene. A negative control with no DNA template and a positive control consisting of 20 μL of DNA obtained from the P. aeruginosa strain ATCC 27853 were used in all reactions. The PCR reaction was performed in a 100 μL reaction mixture containing 30 pmol of each primer, 10 μL of 10 X PCR buffer, 1.5 mM of MgCl2, 0.2 mM of desoxynucleotide triphosphate mixture (final concentration 0.2 mM each dATP, dCTP, dTTP and dGTP), 2 U of Platinum® Taq DNA polymerase (Invitrogen, Grand Island, NY) and 20 μL of DNA template. The reaction was performed in a thermal cycler Primus 25/96, MWG (Biotech, Ebersberg, Germany). The initial denaturation step occurred at 95 °C for 2 min, and was followed by 30 cycles of denaturation at 94 °C for 40 s, annealing at 57 °C for 1 min, extension at 72 °C for 1 min, and a final extension at 72 °C for 2 min. The products obtained were analyzed on a 1.5% agarose gel electrophoresis performed at 4 V/cm in Tris-acetate-EDTA buffer (TAE). The gel was stained with 0.5 μg/mL ethidium bromide and visualized on an ultraviolet transilluminator (Bioamerica, Miami, USA) A 100 bp ladder digest (Invitrogen) was used as a standard molecular weight. The expected products after amplification were 250 bp and 510 bp in length. A pair of ubiquitous bacterial primers (5′-AGA GTT TGA TCC TGG CTC AG-3′ and 5′-ACG GCT ACC TTG TTA CGA CTT-3′) designed by Willis was used to indicate the presence of bacterial DNA in the clinical samples, particularly the ones that were P. aeruginosa-negative. For the reaction using the universal 16S rDNA primers, PCR amplification included a 25 μL reaction mixture containing 0.2 mM of forward and reverse universal primers, 2.5 μL of 10× PCR buffer, 2 mM MgCl2, 1.25 U of Platinum® Taq DNA polymerase, and 200 mM of each deoxynucleosidetriphosphate (Invitrogen). The PCR program included an initial denaturation step at 97 °C for 1 min, followed by 30 cycles of a denaturation step at 97 °C for 45 s, a primer annealing step at 55 °C for 45 s, an extension step at 72 °C for 1 min and a final step of 72 °C for 4 min. The presence of bacterial DNA was determined by an amplicon of 1,505 bp in size visualized on a 1.5% agarose gel. Acinetobacter spp. detection was carried out by a nested PCR (Broderick ; Vanbroekhoven ). The first amplification was performed with the bacterial 16S rRNA universal primers 27f, 5′-AGA GTT TGA TCC TGG CTC AG-3′ and 1492r, 5′-TAC GGC TAC CTT GTT ACG ACT T-3′ (amplicon of 1450 bp). Approximately 100 ng of sample DNA was added into a 50 μL PCR mixture containing 0.5 pmol of each primer, 400 μM of each dNTP, 3 mM MgCl2, 10× PCR buffer (20 mM Tris-HCl [pH 8.4], 50 mM KCl), and 1.5 U Platinum® Taq DNA polymerase (Invitrogen). The amplification program included an initial step of 95 °C for 5 min followed by 35 cycles of denaturation at 94 °C for 30 s, 55 °C for 1 min, 72 °C for 1 min, and a final step of 72 °C for 5 min [34]. The second amplification was performed with the primers Ac436f, 5′-TTT AAG CGA GGA GGA GG-3′ and Ac676r, 5′-ATT CTA CCA TCC TCT CCC-3′ (amplicon of 280 bp) in a reaction volume of 50 μL containing 2 pmol of primer Ac436f, 1 pmol of primer Ac676r, 200 μM of each dNTP, 2 mM MgCl2, 10× PCR buffer, and 1.5 U Platinum® Taq DNA polymerase (Invitrogen). The amplification programme was carried out according to Vanbroekhoven .

Statistical analysis

All statistical tests were performed using the Statistical Package for the Social Sciences (SPSS Inc®.v.10 Chicago, IL, version 17). Full-mouth clinical measurements were computed for each subject and then average across subjects within the groups. Differences on clinical parameters between groups were sought using Mann-Whitney and χ2 tests. The frequency of detection of P. aeruginosa and Acinetobacter spp. were computed for each subject, and significant differences between groups were sought using the χ2 test. Associations between demographic and periodontal parameters, and the frequency of P. aeruginosa and Acinetobacter spp. were examined by the χ2 test. Predictor variables for periodontitis were investigated using multivariate logistic regression analysis, from which ORs with 95% CI were reported. Statistical significance was reached at the 5% level.

Results

The demographic and periodontal clinical features of the subject groups are shown in Table 1. CP patients comprised of a significantly higher proportion of smokers (p < 0.01, Chi-square test) and older individuals (p < 0.01; Mann-Whitney test) than PH subjects. No significant differences between groups were observed for gender. As expected, all clinical parameters of periodontal tissue destruction and inflammation (tooth loss, PD, CAL, BOP, SB and SUP) were significantly greater in the CP group compared to controls (p < 0.01; Mann-Whitney test).
Table 1

Demographic and full-mouth clinical parameters (mean ± SD) of Periodontally Healthy (PH) and Chronic Periodontitis (CP) subjects of the study population.

Clinical parametersPH (N = 55)CP (N = 169)
(%) Males3135
(%) Smokers**625
Age (years)*31.1 ± 1140.2 ± 14
Number of missing teeth*0.95 ± 1.65.6 ± 5.7
Probing depth (mm)*1.9 ± 0.52.9 ± 1.1
Clinical attachment level (mm)*2.0 ± 0.63.7 ± 1.5
% sites with:
Bleeding on probing*2.5 ± 4.743 ± 28
Supragingival biofilm*11.5 ± 1145 ± 30
Suppuration*02 ± 7

Refers to p < 0.01, Mann-Whitney test;

refers to p < 0.01, Chi-square test.

Demographic and full-mouth clinical parameters (mean ± SD) of Periodontally Healthy (PH) and Chronic Periodontitis (CP) subjects of the study population. Refers to p < 0.01, Mann-Whitney test; refers to p < 0.01, Chi-square test. Overall, P. aeruginosa was detected in 40% and Acinetobacter spp. in 45% of all samples. The frequency of P. aeruginosa and Acinetobacter spp. in saliva and biofilm samples from both clinical groups are depicted in Figures 1 and 2. In saliva samples, a significant higher prevalence of P. aeruginosa and Acinetobacter spp. were observed in CP subjects (49.7% and 51%, respectively) compared to PH controls (14.6% and 24.4%, respectively) [p < 0.01; Chi-square test]. Likewise, P. aeruginosa and Acinetobacter spp. were detected significantly more often in subgingival biofilm samples from CP (52.2% and 56.5%, respectively) than PH subjects (11.4% and 31.4%, respectively) [p < 0.01; Chi-square test]. Due to significant differences in smoking status and age between CP and PH, the prevalence of P. aeruginosa and Acinetobacter spp. were evaluated only in non-smokers and subjects with ≤ 35 years of age. Both pathogens were more frequently detected in CP than PH subjects (p < 0.05; Chi-square test, data not shown). Moreover, there were no significant differences in the distribution of P. aeruginosa and Acinetobacter spp. between men and women, subgingival biofilm and saliva samples, patients ≤ 35 and > 35 years of age, and smokers and non-smokers regardless periodontal status (p > 0.05, Chi-square test, Table 2). Associations between P. aeruginosa and Acinetobacter spp. and clinical parameters of disease were also examined (Table 2). For this analysis, only subgingival biofilm samples were considered. Patients with large proportions of visible supragingival biofilm, generalized BOP and periodontal destruction (PD and CAL > 4 mm) presented higher frequencies of P. aeruginosa and Acinetobacter spp. compared to individuals with less signs of disease (p < 0.01, Chi-square test, Table 2). In addition, a strong association between the detection of both species was found. Of the samples positive for P. aeruginosa, 76.4% were also positive for Acinetobacter spp., whereas of the samples negative for P. aeruginosa, 75.2% were negative for Acinetobacter spp. (p < 0.001, Chi-square test, data not shown).
Figure 1

Frequency of detection of P. aeruginosa in saliva and subgingival biofilm samples from periodontally healthy (N = 55) and chronic periodontitis subjects (N = 169). * Significant difference between groups for saliva and biofilm samples (p < 0.05; χ2 test).

Figure 2

Frequency of detection of Acinetobacter spp. in saliva and subgingival biofilm samples from periodontally healthy (N = 55) and chronic periodontitis subjects (N = 169). * Significant difference between groups for saliva and biofilm samples (p < 0.05; χ2 test).

Table 2

Association between the frequency (%) of P. aeruginosa and Acinetobacter spp. and demographic and periodontal clinical parameters in all subjects.

Demographic and clinical parameters% P. aeruginosa% Acinetobacter spp.
Gender
males3744
females4246
Smoking status
non-smokers3943
smokers4658
Age
≤ 35 years3543
> 35 years4447
Type of sample
Saliva4245
Subgingival biofilm3546
Probing depth *
≤ 4 mm1628.4
> 4 mm5565
Clinical attachment level *
≤ 4 mm16.329
> 4 mm5057
Bleeding on probing *
≤ 30% of sites1529
> 30% of sites5456
Supragingival biofilm *
≤ 30% of sites1427
> 30% of sites5056

Refers to p < 0.01, Chi-square test.

Frequency of detection of P. aeruginosa in saliva and subgingival biofilm samples from periodontally healthy (N = 55) and chronic periodontitis subjects (N = 169). * Significant difference between groups for saliva and biofilm samples (p < 0.05; χ2 test). Frequency of detection of Acinetobacter spp. in saliva and subgingival biofilm samples from periodontally healthy (N = 55) and chronic periodontitis subjects (N = 169). * Significant difference between groups for saliva and biofilm samples (p < 0.05; χ2 test). Association between the frequency (%) of P. aeruginosa and Acinetobacter spp. and demographic and periodontal clinical parameters in all subjects. Refers to p < 0.01, Chi-square test. Stepwise logistic regression was performed in order to examine associations between demographic, clinical and bacterial parameters and periodontal status. Table 3 shows the predictor variables entered in the final model to distinguish between periodontal health and chronic periodontitis. Smokers (OR 10.22, CI 2.61–40.0, p < 0.01) presenting P. aeruginosa (OR 7.68, CI 3.13–18.85, p < 0.001) and high frequencies of supragingival plaque (OR 3.77, CI 1.12–12.62, p < 0.05) were more likely to present chronic periodontitis than periodontal health.
Table 3

Final model of the stepwise logistic regression analysis including demographic, clinical and bacterial parameters as predictor variables for chronic periodontal disease.

Variables **βOR*Lower 95% CIUpper 95% CIp
Constant−1.350.26< 0.001
Smoker2.3210.222.6140.0< 0.01
Pseudomonas aeruginosa2.047.683.1318.85< 0.001
Supragingival biofilm1.333.771.1212.62< 0.05

Reference: Periodontally healthy;

Variables entered on step 1: gender (male 1/female 0), smoking (smokers 1/non-smokers 0), age (> 35 years 1/≤ 35 years 0), PD and CAL (> 4 mm 1/≤ 4 mm 0), supragingival biofilm and BOP (> 30% of sites 1/≤ 30% of sites 0), P. aeruginosa and Acinetobacter spp. (positive 1/negative 0).

Final model of the stepwise logistic regression analysis including demographic, clinical and bacterial parameters as predictor variables for chronic periodontal disease. Reference: Periodontally healthy; Variables entered on step 1: gender (male 1/female 0), smoking (smokers 1/non-smokers 0), age (> 35 years 1/≤ 35 years 0), PD and CAL (> 4 mm 1/≤ 4 mm 0), supragingival biofilm and BOP (> 30% of sites 1/≤ 30% of sites 0), P. aeruginosa and Acinetobacter spp. (positive 1/negative 0).

Discussion

Over the last few years, studies have indicated that the presence of non-oral species in the oral microbiota is not a transitory event or a result of contamination during sampling, and that the oral cavity may be a reservoir for medically important pathogens (Barbosa ; Botero ; Colombo ; Da Silva-Boghossian ; Fourrier ; Fritschi ; Gonçalves ; Slots , 1990; Souto and Colombo, 2008; Souto ). It is possible that in addition to putative periodontal pathogens, species such as Acinetobacter spp. and P. aeruginosa, either associated with oral pathogens or not, may also play a role in the etiopathogenesis of periodontal diseases. The current investigation examined the subgingival biofilm and saliva from patients with chronic periodontitis and periodontal health for the presence of P. aeruginosa and Acinetobacter spp. Data correlating periodontal infection and P. aeruginosa or Acinetobacter spp. colonization have indicated that, in general, the prevalence of these species in the oral cavity gets greater proportions in individuals with periodontitis (Barbosa ; Botero ; Colombo , 2002, 2009; Da Silva-Boghossian ; Fourrier ; Fritschi ; Gonçalves ; Persson ; Slots , 1990; Souto and Colombo, 2008; Souto ). Likewise, our results showed a significantly higher frequency of P. aeruginosa and Acinetobacter spp. in saliva and subgingival biofilm samples from periodontitis patients compared to periodontally healthy control. These species have also been associated with treatment failure in patients with refractory periodontitis treated with mechanical and antimicrobial therapy (Colombo , 2009). Conceivably, the high rates of resistance to multiple prescribed broad spectrum antibiotics, as well as the ability to produce biofilms may result in the persistence of these pathogens in the periodontal pocket after therapy (Pihl ; Smith ; Woods ). Associations between the presence of P. aeruginosa and Acinetobacter spp. and demographic and periodontal clinical parameters were also examined. Both species were detected in significantly higher frequencies in subjects with larger proportions of visible supragingival biofilm, BOP, PD and CAL, reinforcing the relationship of these pathogens with inflammation, tissue destruction and poor oral hygiene (Abe ; Colombo , 2009; Da Silva-Boghossian ; Paju and Scannapieco, 2007; Scannapieco ; Souto and Colombo, 2008; Souto ). Indeed, these microorganisms produce virulence factors of relevance to the pathogenesis of periodontitis. P. aeruginosa is tissue invasive, elaborates extracellular leukotoxins, suppresses lymphocyte proliferation, inactivate complement components, degrades basement membrane laminin and releases potent enterotoxins and endotoxins (Pihl ; Smith ; Woods ). Acinetobacter spp. are considered major nosocomial pathogens (Bergogne-Berezin ) accounting for about 80% of reported infections. Members of the genus seem to have a remarkable ability to develop resistance to even the most potent antimicrobial agents (Towner, 1997). Obana (1986) demonstrated that some clinical isolates had slime-producing ability, and that the slime also enhanced the virulence of other species, indicating the potential role of Acinetobacter in the enhancement of virulence in mixed infections. In structured communities, coaggregation of different bacterial species seems to have evolved as an efficient strategy to optimize local opportunities. Studies have indicated that species of Acinetobacter and Pseudomonas, when inserted in highly organized mixed communities, may cooperatively interact with each other, exhibiting direct metabolic communications and frequent genetic exchanges of multi-drug-resistant genes due to the close evolutionary proximity (Fournier ; Hansen ). We found that over 70% of sites colonized by P. aeruginosa were colonized by Acinetobacter spp. In a previous study with hospitalized individuals, our group also demonstrated a strong association between the oral colonization of these microorganisms (Zuanazzi ). Furthermore, P. aeruginosa and Acinetobacter spp. may interact with other species such as periodontal pathogens. Da Silva-Boghossian demonstrated that Aggregatibacter actinomycetemcomitans, A. baumannii and the red complex (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola) associated with P. aeruginosa in the subgingival microbiota increased significantly the likelihood of a subject having aggressive periodontitis. P. aeruginosa also seemed to have a synergism with A. actinomycetemcomitans increasing the risk for periodontal disease. Likewise, Persson showed that P. aeruginosa along with T. forsythia were independent predictors for periodontal disease. However, the exact mechanisms involved in these complex interactions are not elucidated yet. In summary, our findings provide additional evidence for the oral cavity as a reservoir for P. aeruginosa and Acinetobacter spp., as well as of the association of these microorganisms with the presence of periodontal infection. Considering that eradication of this species from subgingival biofilm in deep periodontal pockets may be limited, close attention should be given to these patients in order to reduce the risk for periodontal breakdown and/or development of systemic diseases caused by these species in other areas of the body.
  42 in total

1.  Subgingival microbiota of Brazilian subjects with untreated chronic periodontitis.

Authors:  Ana Paula V Colombo; Ricardo P Teles; Maria Cynésia Torres; Renata Souto; Wilson Júnior Rosalém; Maria Cláudia S Mendes; Milton Uzeda
Journal:  J Periodontol       Date:  2002-04       Impact factor: 6.993

2.  The pathogenesis of human periodontitis: an introduction.

Authors:  R C Page; K S Kornman
Journal:  Periodontol 2000       Date:  1997-06       Impact factor: 7.589

3.  Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients.

Authors:  F Fourrier; B Duvivier; H Boutigny; M Roussel-Delvallez; C Chopin
Journal:  Crit Care Med       Date:  1998-02       Impact factor: 7.598

4.  Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel.

Authors:  K J Towner
Journal:  J Med Microbiol       Date:  1997-09       Impact factor: 2.472

Review 5.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

6.  Prevalence of 6 putative periodontal pathogens in subgingival plaque samples from Romanian adult periodontitis patients.

Authors:  R W Ali; C Velcescu; M C Jivanescu; B Lofthus; N Skaug
Journal:  J Clin Periodontol       Date:  1996-02       Impact factor: 8.728

7.  Detection of Helicobacter pylori by polymerase chain reaction in the subgingival biofilm and saliva of non-dyspeptic periodontal patients.

Authors:  Renata Souto; Ana Paula Vieira Colombo
Journal:  J Periodontol       Date:  2008-01       Impact factor: 6.993

8.  Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6.

Authors:  Susse Kirkelund Hansen; Janus A J Haagensen; Morten Gjermansen; Thomas Martini Jørgensen; Tim Tolker-Nielsen; Søren Molin
Journal:  J Bacteriol       Date:  2007-04-27       Impact factor: 3.490

Review 9.  Oral biofilms, periodontitis, and pulmonary infections.

Authors:  S Paju; F A Scannapieco
Journal:  Oral Dis       Date:  2007-11       Impact factor: 3.511

10.  Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.

Authors:  Antonella Agodi; Martina Barchitta; Rosalba Cipresso; Loredana Giaquinta; Maria Antonietta Romeo; Carmelo Denaro
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

View more
  22 in total

Review 1.  16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora.

Authors:  Tianhao Liu; Zhongshan Yang; Xiaomei Zhang; Niping Han; Jiali Yuan; Yu Cheng
Journal:  3 Biotech       Date:  2017-10-12       Impact factor: 2.406

2.  The Biofilm Community-Rebels with a Cause.

Authors:  A Wilson Aruni; Yuetan Dou; Arunima Mishra; Hansel M Fletcher
Journal:  Curr Oral Health Rep       Date:  2015-03-01

3.  Effect of Aging on Periodontal Inflammation, Microbial Colonization, and Disease Susceptibility.

Authors:  Y Wu; G Dong; W Xiao; E Xiao; F Miao; A Syverson; N Missaghian; R Vafa; A A Cabrera-Ortega; C Rossa; D T Graves
Journal:  J Dent Res       Date:  2016-01-13       Impact factor: 6.116

4.  Bacterial Populations in Subgingival Plaque Under Healthy and Diseased Conditions: Genomic Insights into Oral Adaptation Strategies by Lactobacillus sp. Strain DISK7.

Authors:  Deepika Sharma; Shikha Sharma; Vijay Pal; Rup Lal; Prabhu Patil; Vishakha Grover; Suresh Korpole
Journal:  Indian J Microbiol       Date:  2019-10-08       Impact factor: 2.461

5.  Transcriptome analysis of Porphyromonas gingivalis and Acinetobacter baumannii in polymicrobial communities.

Authors:  D P Miller; Q Wang; A Weinberg; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2018-08-03       Impact factor: 3.563

6.  Pseudomonas aeruginosa Microcolonies in Coronary Thrombi from Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Gorm Mørk Hansen; Daniel Belstrøm; Martin Nilsson; Steffen Helqvist; Claus Henrik Nielsen; Palle Holmstrup; Tim Tolker-Nielsen; Michael Givskov; Peter Riis Hansen
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

7.  Protective effects of Bacillus subtilis against Salmonella infection in the microbiome of Hy-Line Brown layers.

Authors:  Ju Kyoung Oh; Edward Alain B Pajarillo; Jong Pyo Chae; In Ho Kim; Dae-Kyung Kang
Journal:  Asian-Australas J Anim Sci       Date:  2017-04-19       Impact factor: 2.509

Review 8.  Point-of-care diagnosis of periodontitis using saliva: technically feasible but still a challenge.

Authors:  Suk Ji; Youngnim Choi
Journal:  Front Cell Infect Microbiol       Date:  2015-09-03       Impact factor: 5.293

9.  Microbial profiles at baseline and not the use of antibiotics determine the clinical outcome of the treatment of chronic periodontitis.

Authors:  S Bizzarro; M L Laine; M J Buijs; B W Brandt; W Crielaard; B G Loos; E Zaura
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  Periodontal Status and Subgingival Biofilms in Cystic Fibrosis Adults.

Authors:  Tamara Pawlaczyk-Kamieńska; Renata Śniatała; Halina Batura-Gabryel; Maria Borysewicz-Lewicka; Szczepan Cofta
Journal:  Pol J Microbiol       Date:  2019-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.